Novocure Denmark ApS: Financial statements 2025
CVR: 43071076
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Novocure Denmark ApS (CVR 43071076) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,313,877 and a net result of DKK 52,751 compared with DKK 833,715 the year before. That is a decrease of 86.8% compared with the year before. Equity in the 2025 report amounted to DKK 1,465,999. The solvency ratio was 83.3%.
- Gross Profit
- DKK 1,313,877
- Profit/Loss
- DKK 52,751
- Equity
- DKK 1,465,999
- Total Assets
- DKK 1,760,083
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.3 mio. | 53 t. | 1.5 mio. | 0 |
| 2024 | - | 10 mio. | 834 t. | 1.4 mio. | 5 |
| 2023 | - | 8.3 mio. | 433 t. | 580 t. | 4 |
| 2022 | - | 1.9 mio. | 106 t. | 146 t. | 3 |
Official annual report
How creditworthy is Novocure Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 30, 2025, Ashley Carpenter Cordova has stepped down as director of Novocure Denmark ApS.
Novocure Denmark ApS has published its annual report for 2024. Gross profit came to DKK 9,956,127, and the net result was DKK 833,715.
About Novocure Denmark ApS
Novocure Denmark ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marco Adriano Carrino. The company is owned by Novocure GmbH. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 1,313,877 and a net result of DKK 52,751 compared with DKK 833,715 the year before. Equity in the 2025 report amounted to DKK 1,465,999.